Henrik Isackson

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study

Latva-Rasku, Aino; Rebelos, Eleni; Tuisku, Jouni; Aarnio, Richard et al.

Part of Diabetes Care, 2024

• DOI for SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study

Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant

Jiang, He; Hooper, Charlotte; Kelly, Matthew; Steeples, Violetta et al.

Part of Basic Research in Cardiology, 2021

• DOI for Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant
• Download full text (pdf) of Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant

Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study

Oldgren, Jonas; Laurila, Sanna; Åkerblom, Axel; Latva-Rasku, Aino et al.

Part of Diabetes, obesity and metabolism, p. 1505-1517, 2021

• DOI for Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study

SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study

Latva-Rasku, Aino; Rebelos, Eleni; Tuisku, Jouni; Aarnio, Richard et al.

Part of Diabetes Care, 2024

• DOI for SGLT2 Inhibitor Dapagliflozin Increases Skeletal Muscle and Brain Fatty Acid Uptake in Individuals With Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Positron Emission Tomography Study

Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant

Jiang, He; Hooper, Charlotte; Kelly, Matthew; Steeples, Violetta et al.

Part of Basic Research in Cardiology, 2021

• DOI for Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant
• Download full text (pdf) of Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant

Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study

Oldgren, Jonas; Laurila, Sanna; Åkerblom, Axel; Latva-Rasku, Aino et al.

Part of Diabetes, obesity and metabolism, p. 1505-1517, 2021

• DOI for Effects of 6 weeks of treatment with dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomized, placebo-controlled, exploratory study